Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
A recall issued by Health Canada in 2019 specifically highlights MK-677 as not being authorized in Canada for any use
Evaluation of: Glycerol production (a marker of lipolysis) 2-deoxyglucose uptake (a marker of insulin signaling) DNA synthesis (a marker of proliferation) What they found: AOD-9604 stimulated lipolysis dose-dependently from 10 M, with a plateau at 10 M Full hGH stimulated lipolysis to a similar maximum, but with different kinetics AOD-9604 did not affect glucose uptake or DNA synthesis at all, whereas hGH inhibited both (the classic lipotoxic GH effect) Fragments with different sequence (from the N-terminal part of hGH) had no lipolytic effect Why it matters: This was the first publication of AOD-9604
If symptoms persist despite regular oral supplementation, absorption may be limited
Healthy Fats: Incorporate monounsaturated and polyunsaturated fats
From an oncology perspective, even with proven treatments that have become the standard of care (which is a big deal!), two individuals with identical cancer biomarkers will still have completely different outcomes
US$ 25.09
US$ 21.26
US$ 27.24
US$ 22.46